Introduction The clinical practicability of DNA microarray chip in detecting the presence of
mycobacterial species/isolates directly in the skin tissues has not been evaluated, nor the …

Immunological and molecular advances have modernized diagnostic testing for many
diseases. Although interferon gamma-release and polymerase chain reaction assays have …

Rapid and accurate detection of pathogenic bacteria is important for the treatment of patients
with suitable antibiotics. Here we report the development of a diagnostic DNA microarray for …

Cutaneous mycobacterioses are rare in Germany. Nevertheless, early diagnosis and
subsequent effective treatment requires awareness of these conditions. Moreover …

Atypical mycobacterial skin infections are difficult to diagnose owing to their aspecific
histopathologic presentations and to the presence of few bacteria. Therefore, these …

Fungal diseases in immunocompromised hosts pose significant threats to their prognoses.
An accurate diagnosis and identification of the fungal pathogens causing the infection are …

Humans encounter mycobacterial species due to their ubiquity in different environmental
niches. In many individuals, pathogenic mycobacterial species may breach our first-line …

Low-cost and low-density (LCD) DNA arrays offer an easy way to detect resistance as
minimal laboratory instrumentation is needed. Nucleic acid-based amplification tests allow …

Invasive fungal infections have emerged as a major cause of morbidity and mortality in
immunocompromised patients. Conventional identification of pathogenic fungi in clinical …

ABSTRACT A DNA microarray platform, based on the nucleotide sequences of the internal
transcribed spacer regions (ITS1 and ITS2) of the rRNA gene, was developed to identify 32 …